Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The need for randomization in animal trials: an overview of systematic reviews.
Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Analysis of miRNA in Normal Appearing White Matter to Identify Altered CNS Pathways in Multiple Sclerosis.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Predictors of recurrence following an initial episode of transverse myelitis.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Hypomyelinating disorders: An MRI approach.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Altered intrinsic regional spontaneous brain activity in patients with optic neuritis: a resting-state functional magnetic resonance imaging study.
Improving reporting of multiple sclerosis relapse.
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Proton detection for signal enhancement in solid-state NMR experiments on mobile species in membrane proteins.
Mild cognitive decline. A position statement of the Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA).
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
[Biomarkers in multiple sclerosis (a review and experimental data)].

Pages